CFO Miller sells 118,013 shares at blended avg $7.96; 577.4K shares remain. Stock at $8.08, down 22.6% from 52-week high.
Joseph M. Miller, Chief Financial Officer, executed 2 separate sales totaling 118,013 shares for $939,611.68 on March 3–4, 2025 at prices of $8.00 and $7.92, reducing his holdings by 17.0% to 577.4K shares. The sale occurred near the current price level of $8.08, within the 52-week range of $4.81–$10.44. Aurinia Pharmaceuticals reported strong fundamentals—34.0% annual revenue growth, positive net income of $14.4M, and a P/E of 17.96—but the stock remains 22.6% below its 52-week high. The multi-transaction nature and moderate reduction in position suggest a discrete financial decision rather than a systematic portfolio shift, though the lack of prior trading context limits assessment of whether this aligns with established patterns by this executive.